Drawing for KITCHECK

USPTO serial 99075370

KITCHECK

Reviewed by CopyMark Law Group

Status 730Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
RENNEKER, CHRISTOPHER JOHN
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 730: Status 730 means you filed the first six-month extension to delay filing a Statement of Use after a Notice of Allowance. You must file a Statement of Use or another extension before the new deadline.

Need help with KITCHECK?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $947*

Plus Government fees of $450

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Gregory B. Phillips

Gregory B. Phillips Knobbe, Martens, Olson & Bear LLP2040 Main Street, 14th FloorIrvine, CA 92614United States

Goods and services

ClassDescriptionStatusFirst use
009Electronic database recorded on computer media containing pharmaceutical, medical, healthcare, and life sciences informationACTIVE—
012Carts; Mobile storage carts for commercial use; Mobile storage carts for dispensing pharmaceuticals and medical suppliesACTIVE—
042Testing, analysis, and evaluation of the goods of others to assure compliance with industry standards; Developing quality control, usage, compatibility, and interoperability standards for pharmaceuticals, medical records, medication dispensing systems, and medical supplies; Developing quality control, usage, compatibility, and interoperability standards in for tracking, dispensing, and taking inventory of pharmaceuticals and medical supplies; Developing quality control, usage, compatibility, and interoperability standards for tracking, auditing, assessing, reviewing, and reporting data found in medical records and medication dispensing systems; Developing quality control, usage, compatibility, and interoperability standards for assessing and reviewing data in medical records and medication dispensing systems to formulate a discrepancy resolution processsupply chain management and inventory management systems for pharmaceuticals and medical supplies; Developing quality control, usage, compatibility, and interoperability standards for implementing industry standards for pharmaceuticals, medical records, medication dispensing systems, and medical supplies; Developing quality control, usage, compatibility, and interoperability standards for implementing industry standards for tracking, auditing, assessing, reviewing, and reporting data in medical records and medication dispensing systems; Developing quality control, usage, compatibility, and interoperability standards for auditing medical records and medication dispensing systems; Developing quality control, usage, compatibility, and interoperability standards for reporting data in medical records and medication dispensing systems; Developing quality control, usage, compatibility, and interoperability standards for Testing, analysis, and evaluation of the goods of others to assure compliance with industry standards; Developing quality control, usage, compatibility, and interoperability standards for Providing authentication and verification services for others using computer hardware and software for pharmaceuticals, medical dispensing systems, and medical supplies; Providing temporary use of non-downloadable computer software for providing information and recommendations for purchasing pharmaceuticals, vaccines, and medications; Providing temporary use of non-downloadable computer software for providing information for cost-effective alternatives and products for pharmaceuticals, vaccines, and medications; Providing temporary use of non-downloadable computer software for providing information and recommendations for cost-effective alternatives, alternative suppliers, and products for purchasing pharmaceuticals, vaccines, and medications; Providing temporary use of non-downloadable computer software for providing information and recommendations for alternatives to help alleviate or respond to pharmaceutical, vaccine and medication shortages; Providing temporary use of non-downloadable computer software for providing information and recommendations for compliance with contracts, discount programs, and rebates for purchasing pharmaceuticals, vaccines, and medications; Providing temporary use of non-downloadable computer software for auditing medical records and medication dispensing systems; Providing temporary use of non-downloadable computer software for assessing, reviewing, and auditing prescription and medication records; Providing temporary use of non-downloadable computer software for assessing, reviewing, and auditing prescription and medication records, in particular for purchase pricing, budgeting, discounts, and rebates; Providing temporary use of non-downloadable computer software for assessing, reviewing, and auditing prescription and medication records for contract compliance and Group Purchasing Organizations (GPO) compliance; Providing temporary use of non-downloadable computer software for assessing, reviewing and reporting data trends found in prescription and medication records; Providing temporary use of non-downloadable computer software for assessing and reviewing data in medical records and medication dispensing systems to formulate a discrepancy resolution process; Providing temporary use of non-downloadable computer software for reporting data trends found in medical records and medication dispensing systems; Providing temporary use of non-downloadable computer software for collecting, managing, analyzing, and displaying data related to patient registries, quality improvement, patient support, and patient management in the pharmaceutical, medical, healthcare, and life sciences fields; Providing temporary use of non-downloadable computer software for collecting, managing, analyzing, and displaying data related to auditing medical records and medication dispensing systems; Software as a service (SAAS) services featuring software for tracking, auditing, assessing, reviewing, and reporting data found in medical records and medication dispensing systems; Software as a service (SAAS) services featuring software for auditing medical records and medication dispensing systems; Software as a service (SAAS) services featuring software for reporting data in medical records and medication dispensing systems; Software as a service (SAAS) services featuring software for assessing and reviewing data in medical records and medication dispensing systems to formulate a discrepancy resolution process; Software as a service (SAAS) services featuring software for dispensing pharmaceuticals and medical supplies; Software as a service (SAAS) services featuring software for administering pharmaceuticals; Software as a service (SAAS) services featuring software for implementing industry standards for pharmaceuticals, medical records, medication dispensing systems, and medical supplies; Software as a service (SAAS) services featuring software for implementing industry standards for tracking, auditing, assessing, reviewing, and reporting data in medical records and medication dispensing systems; Software as a service (SAAS) services featuring software for providing information for cost-effective alternatives and products for pharmaceuticals, vaccines, and medications; Software as a service (SAAS) services featuring software for providing information and recommendations for purchasing pharmaceuticals, vaccines, and medications; Software as a service (SAAS) services featuring software for providing information and recommendations for cost-effective alternatives and products for purchasing pharmaceuticals, vaccines, and medications; Software as a service (SAAS) services featuring software for providing information and recommendations for cost-effective alternative suppliers for purchasing pharmaceuticals, vaccines, and medications; Software as a service (SAAS) services featuring software for providing information and recommendations for alternatives to help alleviate or respond to pharmaceutical, vaccine and medication shortages; Software as a service (SAAS) services featuring software for providing information and recommendations for compliance with contracts, discount programs, and rebates for purchasing pharmaceuticals, vaccines, and medications; Software as a service (SAAS) services featuring software for assessing, reviewing, and auditing prescription and medication records; Software as a service (SAAS) services featuring software for assessing, reviewing, and auditing prescription and medication records for purchase pricing, budgeting, discounts, and rebates; Software as a service (SAAS) services featuring software for assessing, reviewing, and auditing prescription and medication records for contract compliance and Group Purchasing Organizations (GPO) compliance; Software as a service (SAAS) services featuring software for assessing, reviewing and reporting data trends found in prescription and medication recordsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 17, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 16, 2026EX1GSOU EXTENSION 1 GRANTED—
Jun 16, 2026EXT1SOU EXTENSION 1 FILED—
Jun 16, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 30, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 4, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 4, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 29, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 1, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 23, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Sep 23, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 23, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 23, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 14, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 14, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 14, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 11, 2025DOCKASSIGNED TO EXAMINER—
Jul 10, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 10, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 10, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance